Medtronic Inc. (NYSE:MDT) EVP Bryan C. Hanson sold 15,000 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $87.00, for a total value of $1,305,000.00. Following the sale, the executive vice president now directly owns 108,717 shares in the company, valued at approximately $9,458,379. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
A number of brokerages recently issued reports on MDT. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Medtronic in a research report on Wednesday, July 6th. Vetr lowered Medtronic from a “buy” rating to a “hold” rating and set a $87.96 target price on the stock. in a research report on Wednesday, June 29th. Credit Suisse Group AG reissued a “buy” rating and issued a $85.00 target price on shares of Medtronic in a research report on Tuesday, June 28th. Evercore ISI reissued a “buy” rating and issued a $86.50 target price on shares of Medtronic in a research report on Monday, June 27th. Finally, Needham & Company LLC reissued a “buy” rating on shares of Medtronic in a research report on Monday, June 27th. Seven equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $87.88.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 27th. Investors of record on Friday, July 8th will be given a $0.43 dividend. The ex-dividend date of this dividend is Wednesday, July 6th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.97%. This is a boost from Medtronic’s previous quarterly dividend of $0.38.
Medtronic (NYSE:MDT) last issued its quarterly earnings data on Tuesday, May 31st. The medical technology company reported $1.27 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.26 by $0.01. The business earned $7.57 billion during the quarter, compared to analysts’ expectations of $7.49 billion. During the same quarter last year, the business posted $1.16 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. On average, equities analysts expect that Medtronic Inc. will post $4.66 earnings per share for the current fiscal year.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
